“I am happy for the order which shows that our distributor now has started active sales work of Neo-Bilirubin” says Magdalena Tharaldsen, Director International Business Development at Calmark.
This information is information that Calmark Sweden AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 26 April 2022, 17:00 CEST.
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.